Face of Lobbying Changes  WTO members led by India and South Africa are pushing for a waiver from Intellectual Property (IP) protections for any goods related to COVID-19. Specifically, they want to freely replicate the vaccines that have been developed by private companies like Pfizer, Moderna, and AstraZeneca. The manufacturers of these drugs argue that the hurdle to having more vaccines available is “complex logistical, engineering, and technical challenges of rapidly scaling-up their manufacture” that would not be resolved by simply giving away the technology. However, the more notable aspect of the manufacturers’ plea to the U.S. government to deny the IP waiver is the coalition it cobbled together in support of...